![Christopher Bulow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Bulow
Oprichter bij ResistanceBio, Inc.
Actieve functies van Christopher Bulow
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ResistanceBio, Inc.
![]() ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Financieel Directeur/CFO | - | - | |
Oprichter | - | - |
Loopbaan van Christopher Bulow
Eerdere bekende functies van Christopher Bulow
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Viosera Therapeutics Inc.
![]() Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Operationeel Directeur | 01-07-2016 | - |
Oprichter | 01-07-2016 | - |
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Founder | 2 |
Chief Operating Officer | 1 |
Director/Board Member | 1 |
Sectoraal
Commercial Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Viosera Therapeutics Inc.
![]() Viosera Therapeutics Inc. Miscellaneous Commercial ServicesCommercial Services Viosera Therapeutics Inc. engages in the research and develop services that predict and block drug resistance in cancer and bacteria. The company was founded by Christopher Bulow and Nicholas Goldner and is headquartered in St. Louis, MO. | Commercial Services |
ResistanceBio, Inc.
![]() ResistanceBio, Inc. BiotechnologyHealth Technology ResistanceBio, Inc. is a company that focuses on overcoming treatment-resistant cancer. The company is based in San Carlos, CA. The company's mission is to defeat this type of cancer by developing a novel class of multi-targeted oncology treatments called Resistance Suppressing Therapy (REST). ResistanceBio was founded by Nicholas Goldner and Christopher Bulow, with Nicholas Goldner serving as the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Christopher Bulow
- Ervaring